Showing 131-140 of 328 grants

Title Institution Researcher Program Duration Total Award Amount
microRNA-146a is a potential therapeutic target for type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2024 to 31-May-2027 $600.000,00
Low-dose IL-2 and anti-CD40L as a therapy for type 1 diabetes University of Miami Thomas Malek Cures 01-June-2024 to 31-May-2027 $927.000,00
Gaining insight into type 1 diabetes pathogenesis through STAT gain of function The Regents of the University of California, San Francisco Martin Thelin Cures 01-March-2024 to 28-February-2025 $110.000,00
Goals of Care Among Caregivers of Youth with T1D Using The 3-Act Model Hugo W. Moser Research Institute at Kennedy Krieger Karen Dimentstein Transportfolio 01-September-2024 to 31-August-2026 $130.000,00
Preclinical Optimization of Polyclonal IgM for Type 1 Diabetes Prevention and Reversal Rector & Visitors of the University of Virginia Kenneth Brayman Cures 01-July-2024 to 30-June-2025 $249.458,02
Role of β-cell Golgi dysfunction in Type 1 diabetes pathogenesis The University of Iowa Samuel Stephens Cures 01-June-2024 to 31-May-2027 $750.000,00
Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes Benaroya Research Institute at Virginia Mason Eddie James Cures 01-June-2024 to 31-May-2026 $500.000,00
Local bioelectronic oxygenation for islet engraftment Carnegie Mellon University Tzahi Cohen-Karni Cures 01-August-2024 to 31-July-2027 $974.998,74
Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts Trustees of Columbia University in the City of New York Megan Sykes Cures 01-June-2024 to 31-May-2026 $599.999,94
Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration University of Miami Juan Dominguez-Bendala Cures 01-April-2024 to 31-March-2027 $741.000,00